| A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age (NCT05436834) | ModernaTX, Inc. | 2022-06-21 |
| Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3 (NCT05222425) | Biomad AS | 2022-06-01 |
| A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults. (NCT05354063) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-06-01 |
| A Study of Modified mRNA Vaccines in Healthy Adults (NCT05397223) | ModernaTX, Inc. | 2022-05-24 |
| Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™) (NCT05403346) | Lumos Diagnostics | 2022-05-17 |
| Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster (NCT05897190) | Argorna Pharmaceuticals Co., LTD | 2022-05-16 |
| A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old (NCT05375838) | ModernaTX, Inc. | 2022-05-13 |
| The Safety and Tolerability of A8G6 COVID-19 Neutralization Antibody Combined With Nasal Spray (NCT06127498) | The Second Affiliated Hospital of Chongqing Medical University | 2022-05-01 |
| A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years. (NCT05354089) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-04-27 |
| A Study to Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind (NCT05367908) | ModernaTX, Inc. | 2022-04-11 |
| Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants (NCT05260437) | GlaxoSmithKline | 2022-03-24 |
| AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics (NCT05281601) | AstraZeneca | 2022-03-21 |
| Korea Comirnaty Post-marketing Surveillance (NCT05032976) | Pfizer | 2022-03-18 |
| Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People (NCT05352867) | AIM Vaccine Co., Ltd. | 2022-03-16 |
| High-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients (NCT05280158) | University of California, Los Angeles | 2022-03-10 |
| Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 1) (NCT05194033) | Peking University | 2022-03-09 |
| Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV) (NCT05435027) | Gritstone bio, Inc. | 2022-02-28 |
| Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 2) (NCT05195047) | Peking University | 2022-02-27 |
| A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19 (NCT05249829) | ModernaTX, Inc. | 2022-02-16 |
| A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study. (NCT05181709) | Sean Liu | 2022-02-09 |
| Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX ) (NCT05281692) | Convergent Genomics, Inc. | 2022-02-02 |
| Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease (NCT04412395) | National Research Centre, Egypt | 2022-02-01 |
| Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure (NCT04422626) | University of Pecs | 2022-02-01 |
| Study SARS-CoV-2-CZ-PREVAL-II - Arm of the Olomouc Region (NCT07387211) | The Institute of Molecular and Translational Medicine, Czech Republic | 2022-01-18 |
| Within Household Transmission of COVID-19 Infections (NCT05430516) | UMC Utrecht | 2022-01-15 |
| Biomarkers for Post-COVID Conditions (NCT05196516) | Zealand University Hospital | 2022-01-13 |
| The Effects of a Music Therapy Respiratory Protocol on Post-Covid-19 Respiratory Symptoms (NCT05231512) | Icahn School of Medicine at Mount Sinai | 2022-01-13 |
| Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19 (NCT04844268) | SENAI CIMATEC | 2022-01-13 |
| A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults (NCT05903118) | Argorna Pharmaceuticals Co., LTD | 2022-01-08 |
| Convalescent Plasma Therapy for Hospitalized Patients With COVID-19 (NCT05077930) | Tânia Portella Costa | 2022-01-06 |
| Molnupiravir and COVID-19 Mortality Reduction in the Omicron Era (NCT07720596) | Charles University, Czech Republic | 2022-01-01 |
| A Study of S-268019 for the Prevention of COVID-19 (NCT05212948) | Shionogi | 2021-12-25 |
| Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19 (NCT05137795) | APR Applied Pharma Research s.a. | 2021-12-15 |
| A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters (NCT05137236) | ModernaTX, Inc. | 2021-12-06 |
| Impact of Confinement and Preventive Measures in Period of SARS-COV2 Infection on Clinical Features, Diagnostic and Therapeutic Management and Prognosis of Patients With Lung Cancer (NCT04366219) | Centre Hospitalier le Mans | 2021-12-01 |
| Study to Assess Safety, Reactogenicity and Immunogenicity of the repRNA(QTP104) Vaccine Against SARS-CoV-2(COVID-19) (NCT05876364) | Quratis Inc. | 2021-11-19 |
| COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease (NCT05081388) | Regeneron Pharmaceuticals | 2021-11-08 |
| The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok Community (NCT05047900) | Mahidol University | 2021-11-01 |
| The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19 (NCT04891250) | Centre for Infectious Disease Research in Zambia | 2021-10-01 |
| A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19 (NCT04838847) | CureVac | 2021-10-01 |
| A Study to Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among Immunocompromised Adults (NCT05366322) | ModernaTX, Inc. | 2021-09-10 |
| Detecting SARS-CoV-2 in Tears (NCT04526769) | University of Minnesota | 2021-09-01 |
| Characteristics of Patients With COVID-19 in Meta State, Colombia (NCT04456426) | Hospital Departamental de Villavicencio | 2021-09-01 |
| Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study (NCT04958304) | ModernaTX, Inc. | 2021-09-01 |
| COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States (NCT05020145) | Pfizer | 2021-08-25 |
| Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19 (NCT04854876) | Royal College of Surgeons in Ireland - Medical University of Bahrain | 2021-08-15 |
| Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study) (NCT04967807) | University Health Network, Toronto | 2021-08-05 |
| Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19) (NCT04498325) | Washington University School of Medicine | 2021-07-31 |
| A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above (NCT04847102) | Walvax Biotechnology Co., Ltd. | 2021-07-22 |
| Post-Marketing Safety Study of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in the United States (NCT04958954) | ModernaTX, Inc. | 2021-07-07 |
| SARS-CoV-2/COVID-19 Infection Among Health Care Workers (NCT04826718) | Universidade de Cabo Verde | 2021-07-01 |
| Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc) (NCT05084950) | Centre Scientifique de Monaco | 2021-07-01 |
| Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities (NCT04901624) | University of Southern California | 2021-06-29 |
| Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults (NCT04973449) | AstraZeneca | 2021-06-27 |
| Level of Immunity, Neutralization of the COVID-19 Virus and Reinfections in Residents of 2 Migrant Workers' Residences (NCT04932837) | Epicentre | 2021-06-14 |
| The Effectiveness of Respiratory Tele-rehabilitation After COVID-19 Pneumonia Related: a Randomized Controlled Trial (NCT05007457) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-06-12 |
| Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19) (NCT06775457) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-06-10 |
| Influences of Allergic Rhinitis and Allergen Immunotherapy on SARS-CoV-2 Vaccination (NCT05009134) | Huazhong University of Science and Technology | 2021-06-04 |
| National Survey Concerning Vaccination Against COVID-19 in Nursing Homes and Long-Term Care Units (NCT04779541) | University Hospital, Angers | 2021-06-02 |
| EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19 (NCT05059106) | Federal University of Espirito Santo | 2021-06-01 |
| Emergency Department (ED) Self-Monitoring Pilot COVID-19 (NCT04462783) | University of Michigan | 2021-06-01 |
| Capturing Infectious COVID-19 Asymptomatic Cases in Singapore (NCT04812327) | Becton, Dickinson and Company | 2021-06-01 |
| Risk of SARS-CoV-2 Infection (COVID-19) in a Standing Concert in a Closed Performance Hall (NCT04896970) | University Hospital, Montpellier | 2021-06-01 |
| A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants (NCT04927065) | ModernaTX, Inc. | 2021-05-28 |
| Investigation the Effect of Montelukast in COVID-19 (NCT04718285) | Bahçeşehir University | 2021-05-15 |
| SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector (NCT04939402) | Universitair Ziekenhuis Brussel | 2021-05-05 |
| Protecting Our Community: COVID-19 Testing (NCT04866303) | Montana State University | 2021-04-26 |
| COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities (NCT04860258) | CureVac | 2021-04-22 |
| A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants (NCT04860297) | ModernaTX, Inc. | 2021-04-16 |
| A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults (NCT04591184) | Entos Pharmaceuticals Inc. | 2021-04-07 |
| Neurological Outcome After SARS-CoV-2 Infection (NCT05025839) | Medical University Innsbruck | 2021-04-07 |
| NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons (NCT04799392) | NOWDiagnostics, Inc. | 2021-04-01 |
| Trial to Promote Recovery From COVID-19 With Endocrine Therapy (NCT04374279) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-04-01 |
| Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations (NCT04853004) | Karolinska Institutet | 2021-04-01 |
| Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) (NCT04409873) | University of California, San Francisco | 2021-03-31 |
| To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19 (NCT04709328) | Sinocelltech Ltd. | 2021-03-28 |
| A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age (NCT04796896) | ModernaTX, Inc. | 2021-03-15 |
| Assessment of the Impact of COVID-19 Pandemic on Residents Training and Mental Health in Poland (NCT04753463) | Medical University of Bialystok | 2021-03-15 |
| The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms (NCT04854759) | Independent Public Clinical Hospital No. 4 in Lublin | 2021-03-15 |
| Convalescent Plasma for Early Treatment of COVID-19 (NCT04390503) | Andrew Eisenberger | 2021-03-12 |
| A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19 (NCT04813796) | ModernaTX, Inc. | 2021-03-11 |
| Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients (NCT04414059) | Elsan | 2021-03-10 |
| Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample (NCT04654442) | University Hospital, Grenoble | 2021-03-04 |
| Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid (NCT04822012) | Meir Medical Center | 2021-03-01 |
| Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 Vaccines (NCT05150834) | Korea University Guro Hospital | 2021-02-25 |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic Patients (NCT05074745) | Centre Scientifique de Monaco | 2021-02-18 |
| Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals (NCT04915989) | Genexine, Inc. | 2021-02-16 |
| Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 (NCT04360096) | APR Applied Pharma Research s.a. | 2021-02-15 |
| Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™) (NCT04750629) | Lumos Diagnostics | 2021-02-08 |
| Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV) (NCT04703114) | Assistance Publique - Hôpitaux de Paris | 2021-02-05 |
| Understanding Potential Airborne Transmission and the Protective Value of Type II Surgical Masks in SARS-CoV-2 (NCT04698837) | Insel Gruppe AG, University Hospital Bern | 2021-02-02 |
| Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients (NCT04717011) | Igenomix | 2021-02-01 |
| A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine (NCT04683224) | Vaxxinity, Inc. | 2021-02-01 |
| Asymptomatic SARS-CoV-2 Detection in Children (NCT04853316) | University of Calgary | 2021-01-31 |
| COVID-19 Vaccine Induced Adaptive Immune Responses (NCT04729374) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2021-01-27 |
| COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19 (NCT04703140) | CMC Ambroise Paré | 2021-01-27 |
| Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care (NCT04716985) | AGIR à Dom | 2021-01-22 |
| Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19) (NCT04931238) | Peking Union Medical College Hospital | 2021-01-20 |
| Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients (NCT04654325) | Assistance Publique - Hôpitaux de Paris | 2021-01-19 |
| Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50 (NCT05993143) | Insud Pharma | 2021-01-18 |